# The effects of tetrahydrocannabinol and cannabidiol on sleep in cancer patients

**Authors:** Apoorva C. Reddy, John M. Hampton, Susan J. Park, Faith Dickerson, Betty Chewning, Natalie Schmitz, Kristine Kwekkeboom, Heather Neuman, Amy Trentham-Dietz

PMC · DOI: 10.1007/s12094-025-04069-8 · 2025-10-21

## TL;DR

This study explores how tetrahydrocannabinol (THC) and cannabidiol (CBD) affect sleep in cancer patients, finding that higher CBD doses may improve sleep more effectively.

## Contribution

The study provides new evidence on the relationship between CBD dose and sleep improvement in cancer patients using medical cannabis.

## Key findings

- Higher CBD doses were associated with a 1.87-point improvement in sleep disturbance scores on a 0–10 scale.
- Lower CBD dose quintiles were 29–35% less likely to result in a 30% improvement in sleep disturbance scores.
- THC and THC:CBD ratios showed inconsistent associations with changes in sleep disturbance scores.

## Abstract

Despite limited research, cancer patients are opting for compounds found in cannabis, like tetrahydrocannabinol (THC) and cannabidiol (CBD), to improve their sleep. The purpose of this study was to examine the therapeutic value of cannabis for sleep.

Patient-reported symptom responses were obtained from 1962 cancer patients enrolled in the Minnesota Medical Cannabis Program (MMCP) from 2015 to 2023. Multivariable logistic and linear regression models were used to evaluate the associations between changes in reported sleep disturbance scores and the dose of THC, the dose of CBD, and the cannabinoid ratio (THC:CBD). Logistic and linear regression models were adjusted for sex, age, race, ethnicity, body mass index, and MMCP enrollment fee category. Linear regression models were additionally adjusted for baseline sleep disturbance score.

Compared to the highest quintile category of CBD dose, lower dose quintiles were 29–35% less likely to be associated with at least a 30% improvement in sleep disturbance scores. Sleep disturbance scores improved by 1.87 points on a 0–10 ordinal scale for cancer patients with CBD doses in the top quintile, and approximately 1.5 points for doses in lower quintiles. THC and THC:CBD doses were not consistently related to changes in sleep disturbance scores.

Higher CBD doses may be associated with clinically meaningful improvements in sleep in cancer patients enrolled in a medical cannabis program.

## Linked entities

- **Chemicals:** tetrahydrocannabinol (PubChem CID 16078), THC (PubChem CID 16078), cannabidiol (PubChem CID 644019), CBD (PubChem CID 644019)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), Sleep disturbance (MESH:D012893)
- **Chemicals:** cannabinoid (MESH:D002186), tetrahydrocannabinol (MESH:D013759), CBD (MESH:D002185)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13009030/full.md

---
Source: https://tomesphere.com/paper/PMC13009030